Growth Metrics

Tandem Diabetes Care (TNDM) Net Cash Flow (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3,575.30%
Dec 31, 2025 -109.49%
Sep 30, 2025 205.23%
Jun 30, 2025 164.74%
Mar 31, 2025 -176.43%
Dec 31, 2024 662.65%
Sep 30, 2024 120.01%
Jun 30, 2024 -2,312.92%
Mar 31, 2024 102.52%
Dec 31, 2023 57.95%
Sep 30, 2023 -1,616.13%
Jun 30, 2023 107.35%
Mar 31, 2023 -194.76%
Dec 31, 2022 429.61%
Sep 30, 2022 -57.74%
Jun 30, 2022 -5.28%
Mar 31, 2022 154.48%
Dec 31, 2021 -399.45%
Sep 30, 2021 162.00%
Jun 30, 2021 -185.01%
Mar 31, 2021 174.36%
Dec 31, 2020 62.30%
Sep 30, 2020 -163.15%
Jun 30, 2020 521.90%
Mar 31, 2020 379.15%
Dec 31, 2019 -37.07%
Sep 30, 2019 442.70%
Jun 30, 2019 -66.18%
Mar 31, 2019 -114.57%
Dec 31, 2018 133.66%
Sep 30, 2018 -134.49%
Jun 30, 2018 -124.62%
Mar 31, 2018 2,915.61%
Dec 31, 2017 110.61%
Sep 30, 2017 -17.63%
Jun 30, 2017 -455.11%
Mar 31, 2017 -86.32%
Dec 31, 2016 317.36%
Sep 30, 2016 -18.67%
Jun 30, 2016 -318.08%
Mar 31, 2016 -2,017.95%
Dec 31, 2015 95.69%
Sep 30, 2015 83.67%
Jun 30, 2015 -153.00%
Mar 31, 2015 815.95%
Dec 31, 2014 84.71%
Sep 30, 2014 -127.06%
Jun 30, 2014 73.47%
Mar 31, 2014 -143.70%
Dec 31, 2013 846.33%
Sep 30, 2013 -2,198.37%
Jun 30, 2013 -94.34%